Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:09 PM
NCT ID:
NCT00410956
Group ID:
EG000
Title:
UNRESECTABLE PRIMARY HEPATIC MALIGNANCY
Description:
All patients enrolled in the study will receive HAI FUDR (0.16 mg/kg X pump volume / pump flow rate), Dexamethasone (1 mg/m2/day) and IV Bevacizumab at 5mg/kg. Chemotherapy with HAI FUDR/Dex will commence no sooner than 14 days post surgical placement of HAI pump; patients will receive their first treatment with Bevacizumab no sooner than 28 days post surgical placement of HAI pump.
bevacizumab
dexamethasone
floxuridine
protein expression analysis
flow cytometry
immunoenzyme technique
immunohistochemistry staining method
immunologic technique
laboratory biomarker analysis
dynamic contrast-enhanced magnetic resonance imaging
Deaths Number Affected:
21
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
22
Other Number Affected:
17
Other Number At Risk:
22
Study:
NCT00410956
Results Section:
NCT00410956
Adverse Events Module:
NCT00410956